18F-FDG PET/CT and liquid biopsy are performed 6 week after initiation of therapy with pembrolizumab

2 trials

Sponsors

Takeuchi Satoshi, Hokkaido University Graduate School of Medicine

Conditions

non-small cell lung cancer

Unknown Phase

Early prediction of immune checkpoint inhibitor treatment efficacy in patients with untreated advanced non-small-cell lung cancer

Active, not recruitingJPRN-UMIN000037614

Hokkaido University Graduate School of Medicinenon-small cell lung cancer

Start: 2019-08-01Target: 22Updated: 2026-06-29

Early prediction of immune checkpoint inhibitor treatment efficacy in patients with untreated advanced non-small-cell lung cancer

Active, not recruitingJPRN-jRCT1011200014

Takeuchi Satoshinon-small cell lung cancer

Start: 2020-12-10Target: 22Updated: 2026-06-29